^
BIOMARKER:

RET fusion

i
Other names: RET, Ret Proto-Oncogene, Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret, Cadherin-Related Family Member 16, Rearranged During Transfection, RET Receptor Tyrosine Kinase, Cadherin Family Member 12, Proto-Oncogene C-Ret, CDHF12, CDHR16, PTC, Ret Proto-Oncogene (Multiple Endocrine Neoplasia And Medullary Thyroid Carcinoma 1, Hirschsprung Disease), Multiple Endocrine Neoplasia And Medullary Thyroid Carcinoma 1, Hirschsprung Disease 1, RET-ELE1, HSCR1, MEN2A, MEN2B, RET51, MTC1




Show legend

Include preclinical:
Non Small Cell Lung Cancer
Thyroid Gland Papillary Carcinoma
Pancreatic Cancer
Biliary Tract Cancer
Pancreatic Adenocarcinoma
Colon Cancer
Sarcoma
Solid Tumor
Salivary Gland Cancer
Lung Adenocarcinoma
Neuroendocrine Tumor
Thyroid Gland Carcinoma
Thyroid Gland Follicular Carcinoma
Thyroid Gland Hurthle Cell Carcinoma
Lung Cancer
Fallopian Tube Cancer
Cervical Cancer
Rectal Cancer
Esophageal Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma
Esophageal Squamous Cell Carcinoma
Soft Tissue Sarcoma
Gastric Cancer
Ampulla of Vater Carcinoma
Thyroid Gland Anaplastic Carcinoma
Colorectal Cancer
Peritoneal Cancer
Cholangiocarcinoma
Breast Cancer
Ovarian Cancer
Hepatocellular Cancer
Head and Neck Cancer
Small Intestinal Carcinoma
selpercatinib
pralsetinib
EP0031
lenvatinib
cabozantinib tablet
BOS-172738
KN046
vandetanib
HA121-28
TAS0953/HM06
SY-5007
cabozantinib capsule
everolimus + vandetanib
alectinib + abemaciclib
RET inhibitor
Immunotherapy
durvalumab
palbociclib + alectinib